U.S. STOCKS Stoke Therapeutics, Foot Locker, Marvell
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street's main indexes climbed on Wednesday, with the S&P 500 and the Nasdaq touching record highs driven by gains in technology stocks, while investors awaited comments from U.S. Federal Reserve Chair Jerome Powell later in the day. .N
At 13:30 EST, the Dow Jones Industrial Average .DJI was up 0.38% at 44,873.45. The S&P 500 .SPX was up 0.32% at 6,069.26 and the Nasdaq Composite .IXIC was up 0.91% at 19,657.99.
The top three S&P 500 .PG.INX percentage gainers:
** Salesforce Inc CRM.N, up 8.9%
** ServiceNow Inc NOW.N, up 5.8%
** Edwards Lifesciences Corp EW.N, up 4.9%
The top three S&P 500 .PL.INX percentage losers:
** Texas Pacific Land Corp TPL.N, down 13.3%
** Marketaxess Holdings Inc MKTX.O, down 7.2%
** Campbell's Co CPB.OQ, down 5.7%
The top three NYSE .PG.N percentage gainers:
** Pure Storage Inc PSTG.N, up 21.8%
** Container Store Group Inc TCS.N, up 16.1%
** Lion Electric Co LEV.N, up 14.2%
The top three NYSE .PL.N percentage losers:
** PSQ Holdings Inc PSQH.N, down 33.7%
** Torrid Holdings Inc CURV.N, down 27.9%
** Sos Ltd SOS.N, down 13.6%
The top three Nasdaq .PG.O percentage gainers:
** Cyclerion Therapeutics Inc CYCN.O, up 372.0%
** SMX (Security Matters) PLC SMX.O, up 119.5%
** CN Energy Group Inc CNEY.O, up 87.1%
The top three Nasdaq .PL.O percentage losers:
** Relmada Therapeutics Inc RLMD.O, down 77.2%
** Mawson Infrastructure Group Inc MIGI.O, down 58.1%
** Mondee Holdings Inc MOND.O, down 32.1%
** Novavax Inc NVAX.O:
BUZZ - Rises on $200 mln Czech manufacturing site sale to Novo Nordisk nL3N3N50NS
** Heron Therapeutics Inc HRTX.O:
BUZZ - Jumps on favorable court ruling over Cinvanti patents nL3N3N50RG
** Crescent Energy Co CRGY.N:
BUZZ - Down after $300 mln equity offering to fund Ridgemar deal nL6N3N50IN
** Salesforce Inc CRM.N:
BUZZ - Surges after revenue beats estimates, brokerages raise PT nL3N3N50R9
** Eli Lilly and Co LLY.N:
BUZZ - Gains as weight-loss drug superior to rival Wegovy in trial nL3N3N50PF
** Marvell Technology Inc MRVL.O:
BUZZ - Surges on upbeat Q4 forecast, propelling broader chip sector nL3N3N516J
** General Motors Co GM.N:
BUZZ - Shares down after automaker to take more than $5 bln in charges on China operations nL3N3N50S5
** Dollar Tree Inc DLTR.O:
BUZZ - Rises on upbeat Q3 results nL3N3N50SR
** NexGen Energy Ltd NXE.N:
BUZZ - Up after signing uranium deals with US utilities nL3N3N517P
** Atea Pharmaceuticals Inc AVIR.O:
BUZZ - Rises as combo drug meets main goal in mid-stage study nL3N3N50TN
** Nutrien Ltd NTR.N:
BUZZ - Raymond James upgrades Nutrien to 'outperform', raises PT nL3N3N50XG
** Relmada Therapeutics Inc RLMD.O:
BUZZ - Slumps as depression drug unlikely to meet main trial goal nL3N3N50XQ
** Campbell's Co CPB.N:
BUZZ - Down after Q1 sales miss nL3N3N51AH
** MSC Industrial Direct Co Inc MSM.N:
BUZZ - Stifel downgrades MSC Industrial Direct rating to 'equal weight' nL3N3N50VU
** Robinhood Markets Inc HOOD.O:
BUZZ - Rises after early November trading data nL5N3N516Z
** PSQ Holdings Inc PSQH.N:
BUZZ - Retreats on direct stock offering after Tuesday's skyrocket nL6N3N50K3
** Archer-Daniels-Midland Inc ADM.N:
BUZZ - BMO cuts PT on ADM, sees lower 2025 earnings nL3N3N50XR
** Nano Nuclear Energy Inc NNE.O:
BUZZ - Rises on agreement with US Energy Dept for reactor testing nL3N3N511I
** JetBlue Airways Corp JBLU.O:
BUZZ - Expects smaller annual revenue drop, shares rise nL3N3N5139
** Cracker Barrel Old Country Store Inc CBRL.O:
BUZZ - Up after Q1 results beat nL3N3N50Z1
** Cross Country Healthcare Inc CCRN.O:
BUZZ - Rises over 60% on $615 mln take-private deal nL3N3N514Z
** Royal Bank of Canada RY.N:
BUZZ - Rises after Q4 profit beats estimates nL3N3N516W
** IREN Ltd IREN.O:
BUZZ - Jumps after upsized $400 mln convertible priced nL6N3N50NC
** Generac Holdings Inc GNRC.N:
BUZZ - Barclays starts coverage on Generac with 'equal weight' rating nL3N3N519F
** Stoke Therapeutics Inc STOK.O:
BUZZ - Rises on FDA's 'breakthrough therapy' tag for epileptic disorder drug nL3N3N51A2
** Foot Locker Inc FL.N:
BUZZ - Down after lowering annual sales, profit forecasts nL3N3N51AO
** Trimble Inc TRMB.O:
BUZZ - Rises after J.P. Morgan upgrades to 'overweight' nL3N3N51C5
** Jabil Inc JBL.N:
BUZZ - Stifel raises PT on Jabil ahead of Q1 results nL3N3N51CY
** Marriott International Inc MAR.O:
BUZZ - Truist Securities raises PT on Marriott International nL3N3N51D4
** Airbnb Inc ABNB.O:
BUZZ - Truist Securities cuts PT on Airbnb nL3N3N51DR
The 11 major S&P 500 sectors:
Index RIC | Index name | Percent change % |
.SPX | S&P 500 | 0.32 |
.SPLRCT | S&P 500 Information Technology | 1.36 |
.SPLRCU | S&P 500 Utilities | -0.23 |
.SPLRCD | S&P 500 Consumer Discretionary | 0.64 |
.SPLRCM | S&P 500 Materials | -0.94 |
.SPLRCI | S&P 500 Industrials | 0.08 |
.SPLRCL | S&P 500 Communication Services (Sector) | 0.44 |
.SPSY | S&P 500 Financials | -0.59 |
.SPLRCR | S&P 500 Real Estate | -0.4 |
.SPXHC | S&P 500 Health Care | 0.05 |
.SPLRCS | S&P 500 Consumer Staples | -0.39 |
.SPNY | S&P 500 Energy | -2.82 |
(Compiled by Rajarshi Roy and Puyaan Singh)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.